In vitro and in vivo comparative study of chimeric liver-specific promoters-Reference-Cited by-同舟云学术

In vitro and in vivo comparative study of chimeric liver-specific promoters

Published:2003-03 Issue:3 Volume:7 Page:375-385
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Kramer M.Gabriela,Barajas Miguel,Razquin Nerea,Berraondo Pedro,Rodrigo Manuel,Wu Catherine,Qian Cheng,Fortes Puri,Prieto Jesus

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12;Barajas;Hepatology,2001

2. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus;Villa;Am. J. Gastroenterol.,2001

3. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes;Kay;Proc. Natl. Acad. Sci. USA,1992

4. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits;Chowdhury;Science,1991

5. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse;Wood;Cancer Gene Ther.,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inherently Reduced Expression of ASC Restricts Caspase-1 Processing in Hepatocytes and Promotes Plasmodium Infection;The Journal of Immunology;2023-12-27

2. Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection;Nano Today;2023-12

3. Multivalent Targeting of the Asialoglycoprotein Receptor by Virus‐Like Particles;Small;2023-08-30

4. Inherently reduced expression of ASC restricts caspase-1 processing in hepatocytes and promotesPlasmodiuminfection;2023-07-10

5. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis;JHEP Reports;2023-07